|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
|
Alibaba Health Information Technology Limited is specialized in the direct sale of pharmaceuticals. The turnover is divided across the following activities:
– direct sale of pharmaceuticals (85.2%); – online sale of pharmaceuticals(12.7%); – direct healthcare services (1.8%); – online healthcare services and monitoring of pharmaceuticals (0.3%). The turnover is divided into the revenue sources of product sales…
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
||||
|
||||
Technical analysis trends ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED
| Short Term | Mid-Term | Long Term | |
| Trends | Bullish | Bullish | Bullish |
Income Statement Evolution
|
Sell  Buy |
|
| Mean consensus | OUTPERFORM |
| Number of Analysts | 21 |
| Last Close Price | 7,21 CNY |
| Average target price | 6,89 CNY |
| Spread / Average Target | -4,49% |
